Associated Papers
Developing a disease-specific accessible transcriptional signature as a biomarker for ataxia with oculomotor apraxia type 2.
Ngo KJ et al.
Molecular Medicine (cambridge, Mass.), 2025
40413398 (PubMed )
Supplement: 10020_2025_1257_MOESM4_ESM.xlsx › TableS1_-Study_Cohort_Detailed
Mutation of senataxin alters disease-specific transcriptional networks in patients with ataxia with oculomotor apraxia type 2.
Fogel BL et al.
Human Molecular Genetics, 2014
Select a paper to view details